by CCHR National Affairs Office | May 25, 2023
Advisory adds to concerns that there is insufficient benefit to offset the risk of serious side effects when taking or discontinuing antidepressants. Researchers are advising primary care doctors not to prescribe antidepressants to patients with mild to moderate...
by CCHR National Affairs Office | May 18, 2023
New warning cites high potentital for abuse and misuse of ADHD drugs that can lead to addiction, overdose, and death. The U.S. Food and Drug Administration (FDA) is requiring new warnings in the prescribing information for stimulant drugs used to treat so-called...
by CCHR National Affairs Office | May 10, 2023
Recent research found no benefit to patients’ mental health or any lower risk of suicides from involuntary psychiatric treatment. As National Mental Health Awareness Month draws attention to the importance of good mental health, the Citizens Commission on Human Rights...
by CCHR National Affairs Office | Apr 27, 2023
Another new study found as many as one in four students surveyed at middle schools and high schools reported misusing ADHD drugs in the previous year. A new study found that nearly half of adults using psychostimulant drugs for behavior termed attention-deficit...
by CCHR National Affairs Office | Apr 12, 2023
Researchers highlight the urgent need for proven strategies to reduce the risk, severity and duration of antidepressant withdrawal symptoms. A new survey of antidepressant users who turned to online peer-support groups for advice on withdrawal found that a large...
